Disagree
Home Ultima Pharmaceuticals Ultima Pharmaceuticals
CJC1295 no DAC 2
CJC1295 no DAC 2 - Ultima Pharmaceuticals

CJC1295 no DAC 2 - Ultima Pharmaceuticals

Brand:
Category:
Substance:
Package:
2 mg
Price:
$37.00 - $78.00
See options
Product Overview

Mod GRF 1-29, widely known as CJC-1295 without DAC, enhances natural growth hormone output by simulating the body’s endogenous GHRH. It is engineered for quicker effects and a shorter duration compared to its DAC-containing counterpart. This peptide is valued for its specificity in triggering growth hormone without notable elevations in cortisol, prolactin, or thyroid-stimulating hormone. Users often administer it multiple times daily, syncing with workout routines or sleep for optimal GH response. Used in cycles, it is commonly paired with GHRP peptides, whose different mechanisms complement its action. Mod GRF 1-29 is known for its selective targeting of GH release, supporting benefits in muscle growth, fat reduction, and recovery without the unwanted hormone spillover that some other GH stimulants can cause​​.

References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about CJC1295 no DAC 2 by Ultima Pharmaceuticals, consult with your doctor or healthcare professional.

Products
Show more
Explore More Products
FAQ
Is CJC-1295 without DAC safe to combine with other peptides?
Yes, it’s often combined with GHRP peptides for enhanced growth hormone stimulation.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Does Mod GRF 1-29 affect other hormones like cortisol?
No, it primarily targets growth hormone release without impacting cortisol or prolactin.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

What are common side effects?
Some users experience mild reactions like redness, warmth, or dizziness at the injection site.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.